Literature DB >> 26762269

TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.

Ji-Fang Ma1, Fan Yang2, Saagar N Mahida3, Ling Zhao2, Xiaomin Chen4, Michael L Zhang3, Zhijun Sun5, Yan Yao6, Yi-Xin Zhang2, Gu-Yan Zheng2, Jie Dong2, Ming-Jun Feng4, Rui Zhang1, Jian Sun1, Shuo Li1, Qun-Shan Wang1, Huiqing Cao2, Emelia J Benjamin7, Patrick T Ellinor8, Yi-Gang Li9, Xiao-Li Tian10.   

Abstract

AIMS: Atrial fibrillation (AF) is a common arrhythmia with an important heritable aspect. The genetic factors underlying AF have not been fully elucidated. METHODS AND
RESULTS: We screened six candidate genes (CAV1, KCNJ2, KCNQ1, NKX2.5, PITX2, and TBX5) for novel mutations in 139 patients of Chinese descent with early-onset AF and 576 controls. Four missense TBX5 mutations, p.R355C, p.Q376R, p.A428S, and p.S372L, were identified in evolutionarily conserved regions. We did not find any mutations in CAV1, KCNJ2, KCNQ1, NKX2.5, and PITX2. These mutations increased the expression of atrial natriuretic peptide (ANP) and connexin-40 (CX40) in the primarily cultured rat atrial myocytes but did not alter the expression of cardiac structural genes, atrial myosin heavy chain-α (MHC-α) and myosin light chain-2α (MLC-2α). Overexpression of p.R355C developed an atrial arrhythmia suggestive of paroxysmal AF in the zebrafish model. To replicate our findings, we screened TBX5 in 527 early-onset AF cases from the Massachusetts General Hospital AF study. A novel TBX5 deletion (ΔAsp118, p.D118del) was identified, while no TBX5 mutations were identified in 1176 control subjects.
CONCLUSION: Our results provide both genetic and functional evidence to support the contribution of TBX5 gene in the pathogenesis of AF. The potential mechanism of arrhythmia may be due in part to the disturbed expression of ANP and CX40. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  ANP; Atrial fibrillation; Connexin; Mutation; TBX5

Mesh:

Substances:

Year:  2016        PMID: 26762269      PMCID: PMC4752043          DOI: 10.1093/cvr/cvw003

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  50 in total

1.  Several common variants modulate heart rate, PR interval and QRS duration.

Authors:  Hilma Holm; Daniel F Gudbjartsson; David O Arnar; Gudmar Thorleifsson; Gudmundur Thorgeirsson; Hrafnhildur Stefansdottir; Sigurjon A Gudjonsson; Aslaug Jonasdottir; Ellisiv B Mathiesen; Inger Njølstad; Audhild Nyrnes; Tom Wilsgaard; Erin M Hald; Kristian Hveem; Camilla Stoltenberg; Maja-Lisa Løchen; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

2.  Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation.

Authors:  Mehran Firouzi; Hemanth Ramanna; Bart Kok; Habo J Jongsma; Bobby P C Koeleman; Pieter A Doevendans; W Antoinette Groenewegen; Richard N W Hauer
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367

3.  Common variants in KCNN3 are associated with lone atrial fibrillation.

Authors:  Patrick T Ellinor; Kathryn L Lunetta; Nicole L Glazer; Arne Pfeufer; Alvaro Alonso; Mina K Chung; Moritz F Sinner; Paul I W de Bakker; Martina Mueller; Steven A Lubitz; Ervin Fox; Dawood Darbar; Nicholas L Smith; Jonathan D Smith; Renate B Schnabel; Elsayed Z Soliman; Kenneth M Rice; David R Van Wagoner; Britt-M Beckmann; Charlotte van Noord; Ke Wang; Georg B Ehret; Jerome I Rotter; Stanley L Hazen; Gerhard Steinbeck; Albert V Smith; Lenore J Launer; Tamara B Harris; Seiko Makino; Mari Nelis; David J Milan; Siegfried Perz; Tõnu Esko; Anna Köttgen; Susanne Moebus; Christopher Newton-Cheh; Man Li; Stefan Möhlenkamp; Thomas J Wang; W H Linda Kao; Ramachandran S Vasan; Markus M Nöthen; Calum A MacRae; Bruno H Ch Stricker; Albert Hofman; André G Uitterlinden; Daniel Levy; Eric Boerwinkle; Andres Metspalu; Eric J Topol; Aravinda Chakravarti; Vilmundur Gudnason; Bruce M Psaty; Dan M Roden; Thomas Meitinger; H-Erich Wichmann; Jacqueline C M Witteman; John Barnard; Dan E Arking; Emelia J Benjamin; Susan R Heckbert; Stefan Kääb
Journal:  Nat Genet       Date:  2010-02-21       Impact factor: 38.330

4.  Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.

Authors:  Meenakshi Maitra; Marie K Schluterman; Haley A Nichols; James A Richardson; Cecilia W Lo; Deepak Srivastava; Vidu Garg
Journal:  Dev Biol       Date:  2008-11-20       Impact factor: 3.582

Review 5.  The role of connexin40 in atrial fibrillation.

Authors:  Sevasti-Maria Chaldoupi; Peter Loh; Richard N W Hauer; Jacques M T de Bakker; Harold V M van Rijen
Journal:  Cardiovasc Res       Date:  2009-06-17       Impact factor: 10.787

6.  Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.

Authors:  Brett Burstein; Philippe Comtois; Georghia Michael; Kunihiro Nishida; Louis Villeneuve; Yung-Hsin Yeh; Stanley Nattel
Journal:  Circ Res       Date:  2009-10-29       Impact factor: 17.367

7.  Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.

Authors:  Denice M Hodgson-Zingman; Margaret L Karst; Leonid V Zingman; Denise M Heublein; Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Mariza de Andrade; John C Burnett; Timothy M Olson
Journal:  N Engl J Med       Date:  2008-07-10       Impact factor: 91.245

8.  Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.

Authors:  Robert L Abraham; Tao Yang; Marcia Blair; Dan M Roden; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2009-07-30       Impact factor: 5.000

9.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Authors:  Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

10.  Genome-wide association study of PR interval.

Authors:  Arne Pfeufer; Charlotte van Noord; Kristin D Marciante; Dan E Arking; Martin G Larson; Albert Vernon Smith; Kirill V Tarasov; Martina Müller; Nona Sotoodehnia; Moritz F Sinner; Germaine C Verwoert; Man Li; W H Linda Kao; Anna Köttgen; Josef Coresh; Joshua C Bis; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Fernando Rivadeneira; Albert Hofman; Jan A Kors; Bruno H C Stricker; André G Uitterlinden; Cornelia M van Duijn; Britt M Beckmann; Wiebke Sauter; Christian Gieger; Steven A Lubitz; Christopher Newton-Cheh; Thomas J Wang; Jared W Magnani; Renate B Schnabel; Mina K Chung; John Barnard; Jonathan D Smith; David R Van Wagoner; Ramachandran S Vasan; Thor Aspelund; Gudny Eiriksdottir; Tamara B Harris; Lenore J Launer; Samer S Najjar; Edward Lakatta; David Schlessinger; Manuela Uda; Gonçalo R Abecasis; Bertram Müller-Myhsok; Georg B Ehret; Eric Boerwinkle; Aravinda Chakravarti; Elsayed Z Soliman; Kathryn L Lunetta; Siegfried Perz; H-Erich Wichmann; Thomas Meitinger; Daniel Levy; Vilmundur Gudnason; Patrick T Ellinor; Serena Sanna; Stefan Kääb; Jacqueline C M Witteman; Alvaro Alonso; Emelia J Benjamin; Susan R Heckbert
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  17 in total

Review 1.  Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.

Authors:  Carolina Roselli; Michiel Rienstra; Patrick T Ellinor
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Interplay between cardiac transcription factors and non-coding RNAs in predisposing to atrial fibrillation.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  J Mol Med (Berl)       Date:  2018-05-12       Impact factor: 4.599

3.  T-box family of transcription factor-TBX5, insights in development and disease.

Authors:  Ting Zhu; Longwei Qiao; Qian Wang; Rui Mi; Jinnan Chen; Yaojuan Lu; Junxia Gu; Qiping Zheng
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 4.  Genetics of atrial fibrillation-an update of recent findings.

Authors:  Aarthi Manoharan; Ravikumar Sambandam; Vishnu Bhat Ballambattu
Journal:  Mol Biol Rep       Date:  2022-05-19       Impact factor: 2.742

Review 5.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 6.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

7.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

8.  TBX5 variant with the novel phenotype of mixed‑type total anomalous pulmonary venous return in Holt‑Oram Syndrome and variable intrafamilial heart defects.

Authors:  Bilal Azab; Dunia Aburizeg; Weizhen Ji; Lauren Jeffries; Nooredeen Jamal Isbeih; Amal Saleh Al-Akily; Hashim Mohammad; Yousef Abu Osba; Mohammad A Shahin; Zain Dardas; Ma'mon M Hatmal; Iyad Al-Ammouri; Saquib Lakhani
Journal:  Mol Med Rep       Date:  2022-05-06       Impact factor: 3.423

Review 9.  Multiple Roles of Pitx2 in Cardiac Development and Disease.

Authors:  Diego Franco; David Sedmera; Estefanía Lozano-Velasco
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-11

Review 10.  PITX2-dependent gene regulation in atrial fibrillation and rhythm control.

Authors:  Fahima Syeda; Paulus Kirchhof; Larissa Fabritz
Journal:  J Physiol       Date:  2017-04-25       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.